 Synthetic analogues fumagillin inhibit angiogenesis tumour growth Neovascularization critical growth tumours dominant feature variety angiogenic diseases diabetic retinopathy haemangiomas arthritis psoriasis Recognition potential therapeutic benefit unabated capillary growth search safe effective angiogenesis inhibitors synthesis family novel inhibitors analogues fumagillin antibiotic Aspergillus fumigatus fresenius fungus contaminated culture capillary endothelial cells Purified fumagillin endothelial cell proliferation vitro tumour-induced angiogenesis vivo tumour growth mice administration severe weight loss Synthesis fumagillin analogues potent angiogenesis inhibitors 'angioinhibins growth wide variety tumours side-effects